Pseudohypoaldosteronism Type I (PHA-I) is a rare hereditary disorder of electrolyte metabolism, in which the renal tubules show an apparent loss of response to mineralocorticoids. This condition is characterized by hyperkalemia, metabolic acidosis, hypervolemia, renal salt wasting (or retention), hypotension (or hypertension), and abnormal levels of rennin and aldosterone. The clinical expression of the condition varies from completely asymptomatic individuals, to severely affected infants, in whom the diseases may be lethal. At least two different clinical forms of the disease are known - the purely renal associated PHA-I and a separate form associated with multiple target organ defects (MTOD), in which the kidney, colon, lung, salivary and sweat glands are also affected.
The condition needs to be considered as a differential in the diagnosis of Congenital Adrenal Hypoplasia, especially in boys, due to the similarity of the symptoms. Administration of mineralocorticoids does not seem to work much towards the management of the renal form of the disease. Instead, the condition needs to be treated with fluid and sodium supplementation. The MTOD form is managed by a high-sodium low-potassium diet. In addition, patients exhibiting dyspnea and cyanosis may require external supply of oxygen.